| Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria NW Schmidt, RL Podyminogin, NS Butler, VP Badovinac, BJ Tucker, ... Proceedings of the National Academy of Sciences 105 (37), 14017-14022, 2008 | 315 | 2008 |
| Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells A Moore, P McGuirk, S Adams, WC Jones, JP McGee, DT O'Hagan, ... Vaccine 13 (18), 1741-1749, 1995 | 210 | 1995 |
| Effective induction of high-titer antibodies by viral vector vaccines SJ Draper, AC Moore, AL Goodman, CA Long, AA Holder, SC Gilbert, ... Nature medicine 14 (8), 819-821, 2008 | 209 | 2008 |
| Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice AC Moore, W Kong, BK Chakrabarti, GJ Nabel Journal of virology 76 (1), 243-250, 2002 | 172 | 2002 |
| Coated microneedle arrays for transcutaneous delivery of live virus vaccines A Vrdoljak, MG McGrath, JB Carey, SJ Draper, AVS Hill, C O'Mahony, ... Journal of controlled release 159 (1), 34-42, 2012 | 170 | 2012 |
| The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1 A Moore, L McCarthy, KHG Mills Vaccine 17 (20-21), 2517-2527, 1999 | 163 | 1999 |
| Production of dissolvable microneedles using an atomised spray process: Effect of microneedle composition on skin penetration MG McGrath, S Vucen, A Vrdoljak, A Kelly, C O’Mahony, AM Crean, ... European journal of pharmaceutics and biopharmaceutics 86 (2), 200-211, 2014 | 161 | 2014 |
| Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications P Galvin, D Thompson, KB Ryan, A McCarthy, AC Moore, CS Burke, ... Cellular and Molecular Life Sciences 69, 389-404, 2012 | 159 | 2012 |
| Determination of parameters for successful spray coating of silicon microneedle arrays MG McGrath, A Vrdoljak, C O’Mahony, JC Oliveira, AC Moore, AM Crean International journal of pharmaceutics 415 (1-2), 140-149, 2011 | 158 | 2011 |
| Progress in DNA‐based heterologous prime‐boost immunization strategies for malaria AC Moore, AVS Hill Immunological reviews 199 (1), 126-143, 2004 | 150 | 2004 |
| Inhibition of IL-12 production in human monocyte-derived macrophages by TNF X Ma, J Sun, E Papasavvas, H Riemann, S Robertson, J Marshall, ... The Journal of Immunology 164 (4), 1722-1729, 2000 | 147 | 2000 |
| The success of microneedle-mediated vaccine delivery into skin S Marshall, LJ Sahm, AC Moore Human vaccines & immunotherapeutics 12 (11), 2975-2983, 2016 | 144 | 2016 |
| Single‐dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei A Reyes‐Sandoval, S Sridhar, T Berthoud, AC Moore, JT Harty, ... European journal of immunology 38 (3), 732-741, 2008 | 137 | 2008 |
| Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance AC Moore, A Gallimore, SJ Draper, KR Watkins, SC Gilbert, AVS Hill The Journal of Immunology 175 (11), 7264-7273, 2005 | 126 | 2005 |
| The immune system and stroke: from current targets to future therapy K Malone, S Amu, AC Moore, C Waeber Immunology and cell biology 97 (1), 5-16, 2019 | 111 | 2019 |
| Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods A Vrdoljak, EA Allen, F Ferrara, NJ Temperton, AM Crean, AC Moore Journal of controlled release 225, 192-204, 2016 | 108 | 2016 |
| Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum … M Walther, FM Thompson, S Dunachie, S Keating, S Todryk, T Berthoud, ... Infection and immunity 74 (5), 2706-2716, 2006 | 96 | 2006 |
| Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity CL Hutchings, SC Gilbert, AVS Hill, AC Moore The Journal of Immunology 175 (1), 599-606, 2005 | 94 | 2005 |
| Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1 T Lambe, JB Carey, Y Li, AJ Spencer, A van Laarhoven, CE Mullarkey, ... Scientific reports 3 (1), 1443, 2013 | 93 | 2013 |
| Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody-and T cell-mediated multistage protection against malaria SJ Draper, AL Goodman, S Biswas, EK Forbes, AC Moore, SC Gilbert, ... Cell host & microbe 5 (1), 95-105, 2009 | 93 | 2009 |
Sarah C GilbertProfessor of Vaccinology, Pandemic Sciences Institute, Oxford UniversityВерификована је имејл адреса на ndm.ox.ac.uk